Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29195 | 191 | 24.8 | 38% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
141 | 3 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS | 64640 |
2486 | 2 | PYRAZINAMIDE//ISONIAZID//RIFAMPICIN | 3933 |
29195 | 1 | ACUTE TOXIC MYOPATHY//ANTI TUBERCULOSIS CHEMOPROPHYLAXIS//ANTIBIOTIC RELATED TOXICITY | 191 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACUTE TOXIC MYOPATHY | authKW | 159871 | 1% | 100% | 1 |
2 | ANTI TUBERCULOSIS CHEMOPROPHYLAXIS | authKW | 159871 | 1% | 100% | 1 |
3 | ANTIBIOTIC RELATED TOXICITY | authKW | 159871 | 1% | 100% | 1 |
4 | ANTIPLATELETS ANTIBODIES | authKW | 159871 | 1% | 100% | 1 |
5 | CLIN MED NEFROL 4 | address | 159871 | 1% | 100% | 1 |
6 | CORRECT IL | address | 159871 | 1% | 100% | 1 |
7 | CRESCENTIC RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS | authKW | 159871 | 1% | 100% | 1 |
8 | DESENSITIZAITON THERAPY | authKW | 159871 | 1% | 100% | 1 |
9 | DRUG READMINISTRATION | authKW | 159871 | 1% | 100% | 1 |
10 | HYDRAZINE GROUP | authKW | 159871 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Allergy | 753 | 9% | 0% | 18 |
2 | Tropical Medicine | 576 | 8% | 0% | 16 |
3 | Respiratory System | 531 | 14% | 0% | 27 |
4 | Urology & Nephrology | 519 | 16% | 0% | 30 |
5 | Medicine, General & Internal | 508 | 25% | 0% | 47 |
6 | Dermatology | 75 | 5% | 0% | 10 |
7 | Infectious Diseases | 43 | 5% | 0% | 10 |
8 | Immunology | 42 | 9% | 0% | 17 |
9 | Critical Care Medicine | 39 | 3% | 0% | 6 |
10 | Pharmacology & Pharmacy | 31 | 10% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN MED NEFROL 4 | 159871 | 1% | 100% | 1 |
2 | CORRECT IL | 159871 | 1% | 100% | 1 |
3 | SERV EXPLORAT ALLERGIES PNEUMOLU657 | 159871 | 1% | 100% | 1 |
4 | SERV PNEUMOL ALLERGOL POLE CARDIOVASC THORAC | 159871 | 1% | 100% | 1 |
5 | UNIV TEXAS NORTHEAST | 159871 | 1% | 100% | 1 |
6 | TEXAS INFECT DIS | 79935 | 1% | 50% | 1 |
7 | SERV IBN NAFISS | 53289 | 1% | 33% | 1 |
8 | REG PHARMACOVIGILANCE RENSEIGNEMENT MEDICAM | 31973 | 1% | 20% | 1 |
9 | SERV PNEUMOL IBN NAFISS | 31973 | 1% | 20% | 1 |
10 | REG PHARMACOVIGILANCE INFORMAT MEDICAMENTS | 26644 | 1% | 17% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | 9701 | 4% | 1% | 8 |
2 | TUBERCLE | 8833 | 3% | 1% | 5 |
3 | REVUE FRANCAISE D ALLERGOLOGIE | 7246 | 3% | 1% | 6 |
4 | JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE | 5919 | 1% | 4% | 1 |
5 | ANTIBIOTIKI I MEDITSINSKAYA BIOTEKHNOLOGIYA | 1653 | 1% | 1% | 2 |
6 | NEPHRON | 1619 | 4% | 0% | 7 |
7 | REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE | 1603 | 2% | 0% | 4 |
8 | ANTIBIOTIKI | 1583 | 1% | 0% | 2 |
9 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 1293 | 2% | 0% | 3 |
10 | DICP-THE ANNALS OF PHARMACOTHERAPY | 1265 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | COVIC, A , GOLDSMITH, DJA , SEGALL, L , STOICESCU, C , LUNGU, S , VOLOVAT, C , COVIC, M , (1998) RIFAMPICIN-INDUCED ACUTE RENAL FAILURE: A SERIES OF 60 PATIENTS.NEPHROLOGY DIALYSIS TRANSPLANTATION. VOL. 13. ISSUE 4. P. 924 -929 | 19 | 90% | 35 |
2 | SCHUBERT, C , BATES, WD , MOOSA, MR , (2010) ACUTE TUBULOINTERSTITIAL NEPHRITIS RELATED TO ANTITUBERCULOUS DRUG THERAPY.CLINICAL NEPHROLOGY. VOL. 73. ISSUE 6. P. 413 -419 | 11 | 85% | 4 |
3 | MUTHUKUMAR, T , JAYAKUMAR, M , FERNANDO, EM , MUTHUSETHUPATHI, MA , (2002) ACUTE RENAL FAILURE DUE TO RIFAMPICIN: A STUDY OF 25 PATIENTS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 40. ISSUE 4. P. 690-696 | 13 | 81% | 25 |
4 | SOUZA, CS , ALBERTO, FL , FOSS, NT , (1997) DISSEMINATED INTRAVASCULAR COAGULOPATHY AS AN ADVERSE REACTION TO INTERMITTENT RIFAMPIN SCHEDULE IN THE TREATMENT OF LEPROSY.INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES. VOL. 65. ISSUE 3. P. 366-371 | 13 | 93% | 2 |
5 | FEKIH, L , FENNICHE, S , BOUSSOFFARA, L , HASSENE, H , ABDELGHAFFAR, H , BELHABIB, D , MOHAMED, LM , (2010) HYPERSENSITIVITY REACTIONS TO ANTITUBERCULOUS THERAPY.REVUE DES MALADIES RESPIRATOIRES. VOL. 27. ISSUE 7. P. 673-678 | 11 | 69% | 3 |
6 | MOHAMED, ANM , TUMMINO, C , GOUITAA, M , CHANEZ, P , (2013) THROMBOCYTOPENIA INDUCED BY RIFAMPICIN NOT PREVIOUSLY SENSITIZED: A CASE PRESENTATION.REVUE DES MALADIES RESPIRATOIRES. VOL. 30. ISSUE 9. P. 785-788 | 6 | 100% | 1 |
7 | WEN, YK , CHEN, ML , (2006) CRESCENTIC GLOMERULONEPHRITIS ASSOCIATED WITH RIFAMPICIN IN A PATIENT CO-INFECTED WITH TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS.CLINICAL NEPHROLOGY. VOL. 65. ISSUE 4. P. 284-289 | 10 | 71% | 2 |
8 | MANIKA, K , TASIOPOULOU, K , VLOGIARIS, L , LADA, M , PAPAEMMANOUIL, S , ZAROGOULIDIS, K , KIOUMIS, I , (2013) RIFAMPICIN-ASSOCIATED ACUTE RENAL FAILURE AND HEMOLYSIS: A RATHER UNCOMMON BUT SEVERE COMPLICATION.RENAL FAILURE. VOL. 35. ISSUE 8. P. 1179-1181 | 8 | 73% | 1 |
9 | CHIBA, S , TSUCHIYA, K , SAKASHITA, H , ITO, E , INASE, N , (2013) RIFAMPICIN-INDUCED ACUTE KIDNEY INJURY DURING THE INITIAL TREATMENT FOR PULMONARY TUBERCULOSIS: A CASE REPORT AND LITERATURE REVIEW.INTERNAL MEDICINE. VOL. 52. ISSUE 21. P. 2457-2460 | 8 | 73% | 1 |
10 | PARK, DH , LEE, SA , JEONG, HJ , YOO, TH , KANG, SW , OH, HJ , (2015) RIFAMPICIN-INDUCED MINIMAL CHANGE DISEASE IS IMPROVED AFTER CESSATION OF RIFAMPICIN WITHOUT STEROID THERAPY.YONSEI MEDICAL JOURNAL. VOL. 56. ISSUE 2. P. 582 -585 | 7 | 78% | 1 |
Classes with closest relation at Level 1 |